Cell Therapy Market Size, Share & Trends Analysis Report By Use-type, By Therapy Type (Autologous, Allogenic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2021 - 2028

Cell Therapy Market Size, Share & Trends Analysis Report By Use-type, By Therapy Type (Autologous, Allogenic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2021 - 2028

Cell Therapy Market Growth & Trends

The global cell therapy market size is expected to reach USD 23.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.5% from 2021 to 2028. The emergence of new technologies to support the development of advanced cellular therapies has aided in market growth. Companies are leveraging new technologies not only for the expansion of their product portfolio but also for establishing out-licensing or co-development agreements with other entities to support their product development programs.

Cell-based therapies hold great potential for replacing, repairing, restoring, or regenerating damaged tissues, and organs. Researchers are making huge investments in the development of such effective and safe treatments as an alternative to conventional treatment strategies which can be further attributed to the market growth. Out of all therapeutic areas, oncology has the highest number of ongoing clinical trials. T cells, CD34+ and/or CD133+ stem cells, mesenchymal stem/stromal cells are predominantly employed for clinical investigation.

The majority of biopharmaceutical entities have been affected by the COVID-19 pandemic, while several cellular therapy development companies have witnessed a strongly negative impact, which can be attributed to complications in logistics as well as the manufacturing models employed in this industry. In addition, substantial and stable funding is imperative to ensure successful commercial translation of cell-based therapeutics, a factor that was negatively affected in 2020, further affecting the market growth.

A survey conducted recently among executives of more than 15 European and U.S. cellular therapy companies indicated that disruption caused by the pandemic was significant, which demanded market entities to create strategies to sustain themselves and plan the next wave of innovative therapies.

Key issues faced by companies operating in the market include on-time delivery of therapies to patients at required clinical sites. In addition, the administration of these therapeutics poses several post-pandemic challenges. Hospitals are hesitant in offering services, owing to concerns over transmission of SARS-CoV-2, particularly to vulnerable individuals. Moreover, patients have not been able to visit cellular therapy centers either, owing to the lockdowns and travel bans.

Cell Therapy Market Report Highlights

  • The research-use segment dominated the market and accounted for the highest revenue share in 2020 attributed to extensive research activities for developing effective cell and gene therapies
  • Several cells such as neural, epithelial, bone marrow mononuclear, fibroblasts, corneal, antigen-presenting, and chondrocytes, are being explored for the development of novel therapies
  • The clinical-use segment is expected to witness relatively slow growth through the forecast period owing to the limited number of FDA-approved cellular therapies
  • Moreover, there is a withdrawal of several commercialized products and less number of approved products for clinical-use which further affects the growth of the clinical-use segment
  • Based on the therapeutic area, the malignancies segment accounted for the largest revenue share in 2020 owing to the rising application of stem cells in treating various cancers such as acute myeloid leukemia, multiple myeloma, and non-Hodgkin lymphoma
  • The autologous therapies segment accounted for the largest revenue share in 2020 and it continues the trend through the forecast period owing to the high survival rate associated with this transplant type and relatively high adoption rate
  • The allogenic therapies segment is expected to witness gradual growth through the forecast period owing to the high risk of transplant rejection and high cost associated with allogenic transplants
  • North America has emerged as the highest revenue-generating region in 2020 owing to extensive investments made by the federal bodies for expanding cellular therapy research in the region
  • In Asia Pacific, the market is expected to witness a lucrative growth rate owing to relatively inexpensive manufacturing and operating units, the presence of a large regional population, and untapped potential
Please note The report will be updated with the latest data and delivered to you within 2-3 business days.


e market in investment management firms, 2016 - 2028

8.4 Trading & Exchange Firms
8.4.1 Wealth management software market in trading & exchange firms, 2016 - 2028
8.5 Brokerage Firms
8.5.1 Wealth management software market in brokerage firms, 2016 - 2028
8.6 Others
8.6.1 Wealth management software market in other end use, 2016 - 2028
Chapter 9 Wealth Management Software Regional Outlook
9.1 Wealth Management Software Market Share by Region, 2020
9.2 North America
9.2.1 North America wealth management software market, 2016 - 2028
9.2.2 North America wealth management software market, by advisory mode, 2016 - 2028
9.2.3 North America wealth management software market, by deployment, 2016 - 2028
9.2.4 North America wealth management software market, by application, 2016 - 2028
9.2.5 North America wealth management software market, by enterprise size, 2016 - 2028
9.2.6 North America wealth management software market, by end use, 2016 - 2028
9.2.7 U.S.
9.2.7.1 U.S. wealth management software market, 2016 - 2028
9.2.7.2 U.S. wealth management software market, by advisory mode, 2016 - 2028
9.2.7.3 U.S. wealth management software market, by deployment, 2016 - 2028
9.2.7.4 U.S. wealth management software market, by application, 2016 - 2028
9.2.7.5 U.S. wealth management software market, by enterprise size, 2016 - 2028
9.2.7.6 U.S. wealth management software market, by end use, 2016 - 2028
9.2.8 Canada
9.2.8.1 Canada wealth management software market, 2016 - 2028
9.2.8.2 Canada wealth management software market, by advisory mode, 2016 - 2028
9.2.8.3 Canada wealth management software market, by deployment, 2016 - 2028
9.2.8.4 Canada wealth management software market, by application, 2016 - 2028
9.2.8.5 Canada wealth management software market, by enterprise size, 2016 - 2028
9.2.8.6 Canada wealth management software market, by end use, 2016 - 2028
9.3 Europe
9.3.1 Europe wealth management software market, 2016 - 2028
9.3.2 Europe wealth management software market, by advisory mode, 2016 - 2028
9.3.3 Europe wealth management software market, by deployment, 2016 - 2028
9.3.4 Europe wealth management software market, by application, 2016 - 2028
9.3.5 Europe wealth management software market, by enterprise size, 2016 - 2028
9.3.6 Europe wealth management software market, by end use, 2016 - 2028
9.3.7 U.K.
9.3.7.1 U.K. wealth management software market, 2016 - 2028
9.3.7.2 U.K. wealth management software market, by advisory mode, 2016 - 2028
9.3.7.3 U.K. wealth management software market, by deployment, 2016 - 2028
9.3.7.4 U.K. wealth management software market, by application, 2016 - 2028
9.3.7.5 U.K. wealth management software market, by enterprise size, 2016 - 2028
9.3.7.6 U.K. wealth management software market, by end use, 2016 - 2028
9.3.8 Germany
9.3.8.1 Germany wealth management software market, 2016 - 2028
9.3.8.2 Germany wealth management software market, by advisory mode, 2016 - 2028
9.3.8.3 Germany wealth management software market, by deployment, 2016 - 2028
9.3.8.4 Germany wealth management software market, by application, 2016 - 2028
9.3.8.5 Germany wealth management software market, by enterprise size, 2016 - 2028
9.3.8.6 Germany wealth management software market, by end use, 2016 - 2028
9.4 Asia Pacific
9.4.1 Asia Pacific wealth management software market, 2016 - 2028
9.4.2 Asia Pacific wealth management software market, by advisory mode, 2016 - 2028
9.4.3 Asia Pacific wealth management software market, by deployment, 2016 - 2028
9.4.4 Asia Pacific wealth management software market, by application, 2016 - 2028
9.4.5 Asia Pacific wealth management software market, by enterprise size, 2016 - 2028
9.4.6 Asia Pacific wealth management software market, by end use, 2016 - 2028
9.4.7 China
9.4.7.1 China wealth management software market, 2016 - 2028
9.4.7.2 China wealth management software market, by advisory mode, 2016 - 2028
9.4.7.3 China wealth management software market, by deployment, 2016 - 2028
9.4.7.4 China wealth management software market, by application, 2016 - 2028
9.4.7.5 China wealth management software market, by enterprise size, 2016 - 2028
9.4.7.6 China wealth management software market, by end use, 2016 - 2028
9.4.8 India
9.4.8.1 India wealth management software market, 2016 - 2028
9.4.8.2 India wealth management software market, by advisory mode, 2016 - 2028
9.4.8.3 India wealth management software market, by deployment, 2016 - 2028
9.4.8.4 India wealth management software market, by application, 2016 - 2028
9.4.8.5 India wealth management software market, by enterprise size, 2016 - 2028
9.4.8.6 India wealth management software market, by end use, 2016 - 2028
9.4.9 Japan
9.4.9.1 Japan wealth management software market, 2016 - 2028
9.4.9.2 Japan wealth management software market, by advisory mode, 2016 - 2028
9.4.9.3 Japan wealth management software market, by deployment, 2016 - 2028
9.4.9.4 Japan wealth management software market, by application, 2016 - 2028
9.4.9.5 Japan wealth management software market, by enterprise size, 2016 - 2028
9.4.9.6 Japan wealth management software market, by end use, 2016 - 2028
9.5 Latin America
9.5.1 Latin America wealth management software market, 2016 - 2028
9.5.2 Latin America wealth management software market, by advisory mode, 2016 - 2028
9.5.3 Latin America wealth management software market, by deployment, 2016 - 2028
9.5.4 Latin America wealth management software market, by application, 2016 - 2028
9.5.5 Latin America wealth management software market, by enterprise size, 2016 - 2028
9.5.6 Latin America wealth management software market, by end use, 2016 - 2028
9.5.7 Brazil
9.5.7.1 Brazil wealth management software market, 2016 - 2028
9.5.7.2 Brazil wealth management software market, by advisory mode, 2016 - 2028
9.5.7.3 Brazil wealth management software market, by deployment, 2016 - 2028
9.5.7.4 Brazil wealth management software market, by application, 2016 - 2028
9.5.7.5 Brazil wealth management software market, by enterprise size, 2016 - 2028
9.5.7.6 Brazil wealth management software market, by end use, 2016 - 2028
9.6 MEA
9.6.1 MEA wealth management software market, 2016 - 2028
9.6.2 MEA wealth management software market, by advisory mode, 2016 - 2028
9.6.3 MEA wealth management software market, by deployment, 2016 - 2028
9.6.4 MEA wealth management software market, by application, 2016 - 2028
9.6.5 MEA wealth management software market, by enterprise size, 2016 - 2028
9.6.6 MEA wealth management software market, by end use, 2016 - 2028
Chapter 10 Competitive Landscape
10.1 Comarch SA
10.1.1 Company overview
10.1.2 Financial performance
10.1.3 Product benchmarking
10.1.4 Strategic initiatives
10.2 Dorsum Ltd.
10.2.1 Company overview
10.2.2 Financial performance
10.2.3 Product benchmarking
10.2.4 Strategic initiatives
10.3 Fidelity National Information Services, Inc.
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 Finantix
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 Fiserv, Inc.
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Objectway S.p.A.
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiative
10.7 Profile Software
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiative
10.8 SEI Investments Company
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 SS&C Technologies Holdings, Inc.
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 Temenos Headquarters SA
10.10.1 Company overview
10.10.2 Financial performance
10.10.3 Product benchmarking
10.10.4 Strategic initiatives
10.11 List of Prominent Market Players"
"
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
Chapter 3. Disposable Cups Market Variables, Trends & Scope
3.1. Market Introduction
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Sales/Retail Channel Analysis
3.3.2. Profit Margin Analysis
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.4.4. Industry Opportunities
3.5. Business Environment Analysis
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from New Entrant
3.5.1.5. Competitive Rivalry
3.6. Roadmap of Disposable Cups Market
3.7. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
4.1. Consumer Trends and Preferences
4.2. Factors Affecting Buying Decision
4.3. Consumer Product Adoption
4.4. Observations & Recommendations
Chapter 5. Disposable Cups Market: Product Estimates & Trend Analysis
5.1. Product Movement Analysis & Market Share, 2020 & 2028
5.2. Paper
5.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.3. Plastic
5.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.4. Foam
5.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 6. Disposable Cups Market: End-use Estimates & Trend Analysis
6.1. End-use Movement Analysis & Market Share, 2020 & 2028
6.2. Commercial
6.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
6.3. Institutional
6.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
6.4. Household
6.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 7. Disposable Cups Market: Regional Estimates & Trend Analysis
7.1. Regional Movement Analysis & Market Share, 2020 & 2028
7.2. North America
7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.2.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.2.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.2.4. U.S.
7.2.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.2.4.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.2.4.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.3. Europe
7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.3.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.3.4. Germany
7.3.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.4.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.3.4.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.3.5. U.K.
7.3.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.5.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.3.5.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.4.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.4.4. China
7.4.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.4.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.4.4.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.4.5. India
7.4.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.5.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.4.5.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.5. Central & South America
7.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.5.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.5.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.5.4. Brazil
7.5.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.5.4.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.5.4.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.6. Middle East & Africa (MEA)
7.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.6.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.6.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
7.6.4. South Africa
7.6.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.6.4.2. Market estimates and forecast, by product, 2016 - 2028 (USD Million)
7.6.4.3. Market estimates and forecast, by end use, 2016 - 2028 (USD Million)
Chapter 8. Competitive Analysis
8.1. Key Global Players, Recent Developments & Their Impact on The Industry
8.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. Key Company Market Share Analysis, 2020
Chapter 9. Company Profiles
9.1. Huhtamäki Oyj
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Dart Container Corporation
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Berry Global Group Inc.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. Pactiv LLC
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. DUNI AB
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. WestRock Company
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. Genpak, LLC
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
9.8. Go-Pak UK Ltd.
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Strategic Initiatives
9.9. ConverPack Inc.
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiatives
9.10. Benders Paper Cups
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings